GlassScriptPhysician profile
Frederick W Ehret
NPI 1639153232
$12,222.53
in general payments reported to CMS, 2019-2025
12 companies · $4,722 in 2025
The $4,722 reported for 2025 was more than what 92% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,297 · 2020: $298 · 2021: $214 · 2022: $877 · 2023: $364 · 2024: $451 · 2025: $4,722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,500 · Food and Beverage: $2,138 · Travel and Lodging: $812 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,500.00 |
| Food and Beverage | $2,137.55 |
| Travel and Lodging | $811.64 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $5,227.27 | 2019-2022 | |
| Motiva USA, LLC | $4,507.68 | 2024-2025 | |
| Sientra, INC. | $946.94 | 2019-2022 | |
| Abbvie INC. | $610.53 | 2023-2025 | |
| Mentor Worldwide LLC | $326.92 | 2019-2025 | Mentor Siltex Round Spectrum |
| Davol INC. | $271.22 | 2022-2024 | Phasix Mesh |
| Horizon Therapeutics Plc | $141.34 | 2020-2023 | Tepezza |
| Baxter Healthcare | $86.01 | 2023-2025 | Artiss |
| Integra Lifesciences Corporation | $36.91 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Merck Sharp & Dohme LLC | $29.01 | 2021-2023 | Bridion |
| Merz North America, INC. | $21.74 | 2019 | |
| Galderma Laboratories, L.P. | $16.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Ehret listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.